{"id":48477,"date":"2025-04-22T14:16:16","date_gmt":"2025-04-22T12:16:16","guid":{"rendered":"https:\/\/www.maiwald.eu\/?post_type=publikationen&p=48477"},"modified":"2025-04-23T14:41:05","modified_gmt":"2025-04-23T12:41:05","slug":"maiinsight-issue-2-out-now","status":"publish","type":"publikationen","link":"https:\/\/www.maiwald.eu\/en\/publications\/maiinsight-issue-2-out-now\/","title":{"rendered":"MAIinsight Issue 2 out now!"},"content":{"rendered":"\n
\n
\n
\n
\n

MAI<\/strong>insigh<\/em>t is back for Issue 2!
<\/h2>\n\n\n\n

This time, we focus on EU legislation and bring you articles on the progress of proposals for new laws on plants generated by new genomic techniques (NGT) and unitary Supplementary Protection Certificate (SPC), as well as on the \u2018long-arm\u2019 jurisdiction of courts in the EU being established by recent case law. Additionally, MAI<\/strong>insight<\/em> Issue 2 offers EPO insights on when the recited purpose in a \u2018method for\u2019 claim is limiting and takes a closer look at decision T 56\/21 regarding the adaptation of the description of a European patent application. And finally, we take a deep-dive into the real costs of litigation before the UPC.

Many thanks to all of our authors:
Dr. Regina Neuefeind, Asim Akbani,
Dr. Christian Meyer, Tobias Matschke,
Dr. Michaela Weigel-Krusemarck,
Heike R\u00f6der-Hitschke, Dr. Alexander Schmitz,
Dr. Kerstin Wolff, and Dr. Annelie W\u00fcnsche.
 
MAI<\/strong>insight<\/em> will appear every few months to bring you updates on major case law and practice developments across all IP-related fields in Europe.

We hope you enjoy reading the second issue!<\/p>\n<\/div><\/div>\n\n\n\n

\n
\"\"<\/a><\/figure>\n\n\n\n

<\/a>MAI<\/strong>insight<\/em> for digital browsing<\/a><\/p>\n\n\n\n

<\/a>MAI<\/strong>insight<\/em> as PDF Download<\/a><\/p>\n\n\n\n

<\/a><\/a>Article: Plants generated by new genomic techniques<\/a><\/p>\n\n\n\n

Article: \u203aLong-arm\u2039 jurisdiction of courts in the EU \u2013 how long is the arm<\/a><\/p>\n\n\n\n

Article: The \u203anew\u2039 SPC System for medicinal products<\/a><\/p>\n\n\n\n

<\/a>Article: A \u203amethod for\u2039 claim \u2013 when is the recited purpose limiting<\/a><\/p>\n\n\n\n

Article: Court fees and recoverable costs at the UPC<\/a><\/p>\n\n\n\n

Article: Actually adapting the description to amended claims<\/a><\/p>\n\n\n\n

<\/a>Subscribe to the Maiwald newsletter and be informed about the latest issue of MAI<\/strong>insight<\/em><\/a><\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-48477","publikationen","type-publikationen","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/48477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen"}],"about":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/types\/publikationen"}],"version-history":[{"count":28,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/48477\/revisions"}],"predecessor-version":[{"id":48633,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/48477\/revisions\/48633"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/media?parent=48477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}